Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 03 04:00PM ET
79.47
Dollar change
+1.64
Percentage change
2.11
%
IndexNDX, S&P 500 P/E23.19 EPS (ttm)3.43 Insider Own7.02% Shs Outstand455.34M Perf Week-7.85%
Market Cap36.27B Forward P/E16.63 EPS next Y4.78 Insider Trans0.00% Shs Float424.41M Perf Month-9.65%
Income1.57B PEG2.02 EPS next Q0.97 Inst Own70.35% Short Float2.58% Perf Quarter7.52%
Sales19.50B P/S1.86 EPS this Y8.97% Inst Trans- Short Ratio2.90 Perf Half Y16.39%
Book/sh16.23 P/B4.90 EPS next Y11.58% ROA4.85% Short Interest10.95M Perf Year-0.30%
Cash/sh5.61 P/C14.15 EPS next 5Y11.50% ROE22.33% 52W Range62.35 - 94.50 Perf YTD2.78%
Dividend Est.0.09 (0.11%) P/FCF21.81 EPS past 5Y-2.54% ROI9.84% 52W High-15.90% Beta1.47
Dividend TTM0.15 (0.19%) Quick Ratio0.79 Sales past 5Y4.14% Gross Margin40.74% 52W Low27.46% ATR (14)2.63
Dividend Ex-DateApr 18, 2024 Current Ratio1.01 EPS Y/Y TTM-8.71% Oper. Margin13.42% RSI (14)38.40 Volatility3.95% 2.41%
Employees51000 Debt/Eq1.31 Sales Y/Y TTM4.22% Profit Margin8.05% Recom1.82 Target Price93.71
Option/ShortYes / Yes LT Debt/Eq1.15 EPS Q/Q97.00% Payout3.97% Rel Volume0.72 Prev Close77.83
Sales Surprise-3.15% EPS Surprise-0.75% Sales Q/Q-1.21% EarningsApr 30 BMO Avg Volume3.78M Price79.47
SMA20-6.53% SMA50-10.08% SMA2004.32% Trades Volume2,701,973 Change2.11%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated HSBC Securities Buy $100
Feb-12-24Upgrade UBS Sell → Neutral $66 → $88
Nov-30-23Initiated Jefferies Hold $80
Nov-27-23Downgrade UBS Neutral → Sell $86 → $66
Sep-19-23Initiated Citigroup Buy $82
Aug-25-23Initiated Argus Buy $80
Aug-16-23Initiated Wells Fargo Overweight $90
Jul-31-23Initiated BofA Securities Neutral $82
Jun-27-23Initiated Morgan Stanley Equal-Weight $76
May-16-23Initiated Oppenheimer Outperform $97
May-03-24 09:53AM
May-02-24 04:05PM
May-01-24 09:30AM
Apr-30-24 04:41PM
04:29PM
12:56PM Loading…
12:56PM
12:37PM
12:21PM
10:54AM
10:32AM
09:30AM
07:30AM
06:20AM
Apr-29-24 09:00AM
Apr-28-24 08:00AM
09:13PM Loading…
Apr-25-24 09:13PM
Apr-24-24 11:34AM
09:30AM
Apr-23-24 05:50PM
01:38PM
Apr-22-24 06:00PM
11:10AM
07:07AM
Apr-19-24 09:55AM
Apr-18-24 10:32AM
09:00AM
Apr-17-24 10:48AM
Apr-16-24 08:00AM
Apr-15-24 01:18PM
Apr-13-24 12:16PM
08:00AM Loading…
Apr-12-24 08:00AM
Apr-09-24 08:05AM
07:37AM
Apr-08-24 01:31PM
Apr-05-24 03:41PM
Apr-04-24 12:03PM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:46PM
07:35AM
07:31AM
Apr-01-24 06:13PM
01:26PM
Mar-28-24 11:30AM
Mar-27-24 08:00AM
Mar-26-24 11:17AM
Mar-25-24 10:20AM
09:00AM
Mar-22-24 11:00AM
10:51AM
12:33AM
Mar-21-24 12:32PM
Mar-19-24 09:30AM
Mar-18-24 06:00PM
Mar-15-24 11:15AM
Mar-14-24 01:30PM
Mar-13-24 04:10PM
09:30AM
Mar-12-24 10:28PM
04:34PM
09:00AM
Mar-11-24 12:33PM
Mar-07-24 11:31AM
09:00AM
Mar-04-24 08:25AM
Mar-01-24 09:40AM
Feb-28-24 08:00AM
Feb-26-24 07:30AM
Feb-20-24 09:50AM
Feb-19-24 10:00AM
Feb-16-24 12:47AM
Feb-15-24 04:55PM
Feb-14-24 04:05PM
09:40AM
09:30AM
Feb-08-24 10:00AM
Feb-06-24 12:02PM
10:41AM
07:45AM
06:20AM
Feb-01-24 08:00AM
Jan-31-24 12:19PM
Jan-29-24 10:50AM
Jan-18-24 08:38AM
Jan-08-24 08:01AM
Dec-22-23 09:03AM
Dec-21-23 09:10AM
Dec-18-23 08:51AM
Dec-08-23 10:10AM
Dec-04-23 10:00AM
Nov-29-23 10:00AM
Nov-28-23 09:46AM
Nov-27-23 04:55PM
10:38AM
Nov-26-23 09:00AM
Nov-21-23 09:30AM
Nov-17-23 11:30AM
Nov-14-23 08:00AM
Nov-13-23 10:00AM
Nov-08-23 08:00AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jimenez Frank RGC & Corporate SecretaryMay 01 '24Buy76.521,315100,62475,796May 02 06:00 AM
O'Neill Kevin MichaelCEO, PDxJul 31 '23Option Exercise40.4013,275536,31037,300Aug 02 04:05 PM
O'Neill Kevin MichaelCEO, PDxJul 31 '23Sale77.3215,6091,206,94924,025Aug 02 04:05 PM
Rott RolandCEO, UltrasoundJun 08 '23Sale77.372,473191,33622,335Jun 12 04:06 PM